We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$3.29B
AUM Growth
+$322M
Cap. Flow
+$111M
Cap. Flow %
3.39%
Top 10 Hldgs %
10.67%
Holding
1,133
New
146
Increased
560
Reduced
374
Closed
47

Top Buys

Rank Stock Value
1
IRTC icon
iRhythm Holdings
IRTC
+$18.1M
2
AAPL icon
Apple
AAPL
+$9.12M
3
ABBV icon
AbbVie
ABBV
+$8.74M
4
META icon
Meta Platforms (Facebook)
META
+$7.28M
5
CMCSA icon
Comcast
CMCSA
+$7.16M

Sector Composition

Rank Sector Weight
1 Technology 29.68%
2 Healthcare 14.09%
3 Energy 12.28%
4 Industrials 10.52%
5 Consumer Discretionary 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUS icon
451
Nu Skin
NUS
$267M
$1.8M 0.05%
31,840
-975
-3% -$55.5K
SUN icon
452
Sunoco
SUN
$13.3B
$1.8M 0.05%
47,846
+4,224
+10% +$150K
TIL icon
453
Instil Bio
TIL
$50.3M
$1.8M 0.05%
+4,662
New +$1.73M
ED icon
454
Consolidated Edison
ED
$39.9B
$1.79M 0.05%
24,899
+1,423
+6% +$109K
EXAS
455
DELISTED
Exact Sciences
EXAS
$1.78M 0.05%
14,336
+1,424
+11% +$170K
WTRG icon
456
Essential Utilities
WTRG
$11.4B
$1.78M 0.05%
38,907
+7,444
+24% +$349K
PRG icon
457
PROG Holdings
PRG
$1.71B
$1.77M 0.05%
36,869
-1,128
-3% -$56.1K
ICE icon
458
Intercontinental Exchange
ICE
$84.4B
$1.77M 0.05%
14,902
+1,843
+14% +$212K
CACI icon
459
CACI
CACI
$14.2B
$1.76M 0.05%
6,909
-213
-3% -$55K
ALNY icon
460
Alnylam Pharmaceuticals
ALNY
$29.3B
$1.76M 0.05%
10,391
-1,206
-10% -$177K
MS icon
461
Morgan Stanley
MS
$340B
$1.76M 0.05%
19,158
+7,132
+59% +$612K
IOVA icon
462
Iovance Biotherapeutics
IOVA
$2.87B
$1.76M 0.05%
67,485
+34,477
+104% +$896K
GS icon
463
Goldman Sachs
GS
$303B
$1.75M 0.05%
4,622
+1,583
+52% +$566K
MXIM
464
DELISTED
Maxim Integrated Products
MXIM
$1.75M 0.05%
16,599
-17,840
-52% -$1.75M
UBA
465
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$1.74M 0.05%
89,955
+2,194
+2% +$40.5K
ACI icon
466
Albertsons Companies
ACI
$5.83B
$1.73M 0.05%
87,730
-2,685
-3% -$52.1K
RCUS icon
467
Arcus Biosciences
RCUS
$3.64B
$1.72M 0.05%
62,765
+7,621
+14% +$218K
F icon
468
Ford
F
$55.7B
$1.72M 0.05%
115,799
+71,163
+159% +$946K
HST icon
469
Host Hotels & Resorts
HST
$16B
$1.72M 0.05%
100,742
+19,550
+24% +$341K
NKTR icon
470
Nektar Therapeutics
NKTR
$2.58B
$1.72M 0.05%
6,680
-34
-0.5% -$9.41K
UNF icon
471
Unifirst Corp
UNF
$5.25B
$1.71M 0.05%
7,287
-222
-3% -$49.8K
SBGI icon
472
Sinclair Inc
SBGI
$1.03B
$1.71M 0.05%
51,344
-1,572
-3% -$50.8K
THG icon
473
Hanover Insurance
THG
$7.98B
$1.7M 0.05%
12,510
-384
-3% -$52.6K
ATRA icon
474
Atara Biotherapeutics
ATRA
$76.1M
$1.69M 0.05%
4,344
+1,634
+60% +$583K
BLUE
475
DELISTED
bluebird bio
BLUE
$1.68M 0.05%
4,061
+1,102
+37% +$437K

Similar funds

Vident Investment Advisory's Q2 2021 Portfolio in Review

As of Q2 2021, Vident Investment Advisory held 1,133 positions worth $3.29B, up 11% from $2.97B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Vident Investment Advisory deployed $111M of net new capital in Q2 2021, opening 146 new positions and adding to 560 existing holdings. Its largest new stake was XPO: 59,887 shares worth $2.9M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Nuance Communications, Inc., an estimated $29.7M trimmed.

  • Vident Investment Advisory's largest Q2 2021 buy was XPO: 59,887 shares worth $2.9M.
  • Vident Investment Advisory added most to iRhythm Holdings in Q2 2021, an estimated $18.1M increase.
  • Vident Investment Advisory's biggest Q2 2021 reduction was Nuance Communications, Inc., cutting an estimated $29.7M.
  • Vident Investment Advisory fully exited Cooper Tire & Rubber Co. in Q2 2021, selling an estimated $2.79M.
  • Vident Investment Advisory's ten largest holdings make up 11% of its $3.29B portfolio in Q2 2021.
  • Vident Investment Advisory opened 146 new positions and closed 47 in Q2 2021.
  • Vident Investment Advisory's portfolio value rose 11% quarter-over-quarter to $3.29B.

Based on Vident Investment Advisory's 13F filing for Q2 2021, filed 13 Aug 2021.